No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Standard

No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells. / Faber, Carsten; Heegaard, Steffen; Kiilgaard, Jens Folke.

I: Case Reports in Ophthalmological Medicine, Bind 2019, 6927829, 12.2019.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning

Harvard

Faber, C, Heegaard, S & Kiilgaard, JF 2019, 'No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells', Case Reports in Ophthalmological Medicine, bind 2019, 6927829. https://doi.org/10.1155/2019/6927829

APA

Faber, C., Heegaard, S., & Kiilgaard, J. F. (2019). No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells. Case Reports in Ophthalmological Medicine, 2019, [6927829]. https://doi.org/10.1155/2019/6927829

Vancouver

Faber C, Heegaard S, Kiilgaard JF. No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells. Case Reports in Ophthalmological Medicine. 2019 dec.;2019. 6927829. https://doi.org/10.1155/2019/6927829

Author

Faber, Carsten ; Heegaard, Steffen ; Kiilgaard, Jens Folke. / No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells. I: Case Reports in Ophthalmological Medicine. 2019 ; Bind 2019.

Bibtex

@article{6509074e8fea4cf08c63acc402d72b21,

title = "No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells",

abstract = "This study reports findings from a 56-year-old patient, who had received bilateral intravitreal injection of putative adipose tissue-derived stem cells at a private clinic in India with the promise of treatment of NAION. During an observation period of 8, respectively, 18 months, the intravitreally injected cells remained silent in the vitreous bodies without either therapeutic effects or complications. The cells cleared with vitrectomy without evidence of integration in the optic nerve or retina. Contrary to recent reports on patients receiving intravitreal injections of similar putative stem cells with the aim of treating AMD, our patient suffered no devastating ocular consequences. Summary. Contrary to recent reports, this case demonstrated no devastating consequences of intravitreal injection of adipose tissue-derived stem cells during an observation period of up to 18 months. After vitrectomy, the cells cleared without evidence of either harm or integration.",

author = "Carsten Faber and Steffen Heegaard and Kiilgaard, {Jens Folke}",

note = "Copyright {\textcopyright} 2019 Carsten Faber et al.",

year = "2019",

month = dec,

doi = "10.1155/2019/6927829",

language = "English",

volume = "2019",

journal = "Case Reports in Ophthalmological Medicine",

issn = "2090-6722",

publisher = "Hindawi Publishing Corporation",

}

RIS

TY - JOUR

T1 - No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells

AU - Faber, Carsten

AU - Heegaard, Steffen

AU - Kiilgaard, Jens Folke

PY - 2019/12

Y1 - 2019/12

N2 - This study reports findings from a 56-year-old patient, who had received bilateral intravitreal injection of putative adipose tissue-derived stem cells at a private clinic in India with the promise of treatment of NAION. During an observation period of 8, respectively, 18 months, the intravitreally injected cells remained silent in the vitreous bodies without either therapeutic effects or complications. The cells cleared with vitrectomy without evidence of integration in the optic nerve or retina. Contrary to recent reports on patients receiving intravitreal injections of similar putative stem cells with the aim of treating AMD, our patient suffered no devastating ocular consequences. Summary. Contrary to recent reports, this case demonstrated no devastating consequences of intravitreal injection of adipose tissue-derived stem cells during an observation period of up to 18 months. After vitrectomy, the cells cleared without evidence of either harm or integration.

AB - This study reports findings from a 56-year-old patient, who had received bilateral intravitreal injection of putative adipose tissue-derived stem cells at a private clinic in India with the promise of treatment of NAION. During an observation period of 8, respectively, 18 months, the intravitreally injected cells remained silent in the vitreous bodies without either therapeutic effects or complications. The cells cleared with vitrectomy without evidence of integration in the optic nerve or retina. Contrary to recent reports on patients receiving intravitreal injections of similar putative stem cells with the aim of treating AMD, our patient suffered no devastating ocular consequences. Summary. Contrary to recent reports, this case demonstrated no devastating consequences of intravitreal injection of adipose tissue-derived stem cells during an observation period of up to 18 months. After vitrectomy, the cells cleared without evidence of either harm or integration.

U2 - 10.1155/2019/6927829

DO - 10.1155/2019/6927829

M3 - Journal article

C2 - 31976105

VL - 2019

JO - Case Reports in Ophthalmological Medicine

JF - Case Reports in Ophthalmological Medicine

SN - 2090-6722

M1 - 6927829

ER -

ID: 240980403